Racial disparities persist in receipt of curative treatment for early-stage non-small cell lung cancer (NSCLC), according to a study published online March 2 in JAMA Network Open. Olivia F. Lynch, MD, ...

Investigators examined the effects of exercise on cancer-related cognitive impairment (CRCI) and mental fatigue in patients receiving chemotherapy in a multicenter phase III randomized controlled ...

Arm lymphedema was reported in 13% of patients in the experimental group and 12% in the control group. Survival and safety outcomes were also similar with both regimens, study researchers reported.

The Independent Data Monitoring Committee concluded that the risk of secondary hematologic malignancies outweighed Tazverik’s potential benefits. Ipsen has decided to voluntarily withdraw Tazverik ® ...

Investigators sought to determine whether complementary and alternative medicine (CAM) affects survival in female patients with breast cancer.

In this study, investigators aimed to explore outcomes following the development of mental health disorders after cancer diagnosis.

The phase 3 SUCCESSOR-2 trial shows mezigdomide-based therapy improves PFS in R/R multiple myeloma patients previously exposed to lenalidomide.

No increased risk for thrombosis or bleeding seen with concurrent use of enzalutamide, apalutamide, or abiraterone with DOACs ...

Data show T-DXd improves invasive disease-free survival and reduces the risk of distant recurrence in early HER2-positive breast cancer.